Latest Articles
-
Alzheimer’s Care: FDA Approves First At-Home Starting Dose
An Alzheimer’s diagnosis brings enormous challenges for both patients and their families. Caregivers often juggle medical appointments, transportation, medications, and everyday responsibilities while trying to provide the best possible care. A recent decision by the U.S. Food and Drug Administration (FDA) may help make one part of that journey a…
-
Longitudinal Research Studies: Questions That Endure
Over the past several months, I’ve found myself deep in the literature of some of the world’s most remarkable longitudinal studies. Like most of us in clinical research, I was initially drawn to their findings. But the more I read, the more I became fascinated by something else entirely: their…
-
Pancreatic Cancer Breakthrough: Daraxonrasib Earns ASCO 2026 Ovation
Pancreatic cancer remains one of the most difficult malignancies to diagnose and treat, largely because early-stage disease is often asymptomatic. Despite decades of research, outcomes for patients with metastatic pancreatic ductal adenocarcinoma have remained poor, with limited treatment options available after first-line therapy fails. Current imaging modalities frequently fail to…








